Clonal spread of pediatric isolates of ciprofloxacin-resistant, emm type 6 Streptococcus pyogenes

Rodrigo Alonso1, Estibaliz Mateo, Marc Galimand

  • 1Departamento de Inmunología, Microbiología y Parasitología, Facultad de Farmacia, Universidad del País Vasco, Paseo de la Universidad, 7 01006-Vitoria-Gasteiz, Spain. oipalmor@vc.ehu.es

Insights

Streptococcus pyogenes isolates resistant to ciprofloxacin showed a specific mutation in the parC gene. This finding is crucial for understanding fluoroquinolone resistance in this bacterium.

Area of Science:

  • Microbiology
  • Genetics
  • Infectious Diseases

Background:

  • Emerging fluoroquinolone resistance in Streptococcus pyogenes poses a significant public health threat.
  • Understanding the genetic basis of this resistance is critical for effective treatment strategies.

Purpose of the Study:

  • To investigate the molecular mechanisms of ciprofloxacin resistance in community-acquired Streptococcus pyogenes isolates.
  • To identify specific genetic mutations associated with reduced susceptibility to fluoroquinolones.

Main Methods:

  • Analysis of 24 Streptococcus pyogenes isolates exhibiting ciprofloxacin resistance.
  • Sequencing of quinolone resistance-determining regions (QRDRs) in the gyrA and parC genes.
  • Pulsed-field gel electrophoresis (PFGE) for strain typing.

Main Results:

  • All 24 isolates were resistant to ciprofloxacin but susceptible to levofloxacin, gatifloxacin, and moxifloxacin.
  • A T/G mutation in the parC gene, resulting in a Ser79Ala substitution in the ParC protein, was identified in all resistant isolates.
  • The majority of isolates belonged to emm type 6, with 18 being indistinguishable and 2 closely related by PFGE.

Conclusions:

  • The identified parC gene mutation (Ser79Ala) is strongly associated with ciprofloxacin resistance in Streptococcus pyogenes.
  • This specific mutation may confer cross-resistance to certain fluoroquinolones while maintaining susceptibility to others.
  • The genetic homogeneity of the emm type 6 isolates suggests a potential clonal spread of this resistant strain.